A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Active:	Yes
Cancer Type:	Unknown Primary	NCT ID:	NCT06585774
Trial Phases:	Phase III	Protocol IDs:	INCA34176-357 (primary) NCI-2025-01061 2023-510292-65-00
Eligibility:	12 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Incyte Corporation
NCI Full Details:	http://clinicaltrials.gov/show/NCT06585774

Summary

This study will be conducted to compare the efficacy of axatilimab versus placebo in
combination with corticosteroids as initial treatment for moderate or severe chronic
graft-versus-host disease (cGVHD).

Treatment Sites in Georgia

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.